Showing results (1711-1720 of 1,926) with videos related to
Sort By:
Pageof 193
RMD Open|April 14, 2017
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPICAnja Weiß, Kirsten Minden, Joachim Listing, et al.RMD Open|April 14, 2017
Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entityC Calabrese, E Kirchner, A Kontzias, et al.RMD Open|March 18, 2021
Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritisDaniel J Lovell, Bin Huang, Chen Chen, et al.RMD Open|February 5, 2022
Development of radiographic classification criteria for hand osteoarthritis: a methodological report (Phase 2)Ida K Haugen, David Felson, Abhishek Abhishek, et al.RMD Open|February 8, 2022
Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccinationPaola Adele Lonati, Caterina Bodio, Mariangela Scavone, et al.RMD Open|April 16, 2022
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 yearsFengchun Zhang, Jie Zheng, Yang Li, et al.RMD Open|September 30, 2021
In vitro evaluation of disease-modifying antirheumatic drugs against rheumatoid arthritis associated pathogens of the oral microfloraManuel Kussmann, Markus Obermueller, Kathrin Spettel, et al.RMD Open|July 27, 2022
'Difficult to treat' rheumatoid arthritis: current position and considerations for next stepsYvonne Tan, Maya H BuchRMD Open|July 29, 2022
Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritisDesiree Tampe, Samy Hakroush, Björn TampeRMD Open|November 2, 2021
Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to considerAlessia Alunno, Aurélie Najm, Xavier Mariette, et al.Pageof 193